Evidence map›Paper›PMID 32237205›Full record

ArticleCancer medicine2020

Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women.

Despina Tsementzi, Angela Pena-Gonzalez, Jinbing Bai, Yi-Juan Hu, Pretesh Patel, Joseph Shelton, Mary Dolan, Jessica Arluck, Namita Khanna, Lesley Conrad and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05122065 (Defining the Vaginal Microbiome and the Vaginal pH of Menopausal Women With and Without Genitourinary Syndrome and With and Without Hormone Replacement Therapy), which is not on this map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05122065 unknown statusnot on this mapstarted 2021, after this paper: background citation

Defining the Vaginal Microbiome and the Vaginal pH of Menopausal Women With and Without Genitourinary Syndrome and With and Without Hormone Replacement Therapy

TypeobservationalSponsorFemTec Health Inc.Ran2021 to 2022Enrolled432ConditionsMenopause, Hormone Replacement Therapy, Genitourinary Syndrome of Menopause
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Profiling of vaginalMicrobial genomics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Despina TsementziNell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, USA.ORCID 0000-0002-4578-1918
Angela Pena-GonzalezSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.
Jinbing BaiNell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, USA.
Yi-Juan HuDepartment of Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA.
Pretesh PatelRadiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Joseph SheltonRadiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Mary DolanDepartment of Obstetrics and Gynecology, Emory University, Atlanta, GA, USA.
Jessica ArluckGrady Memorial Hospital, Atlanta, GA, USA.
Namita KhannaDepartment of Obstetrics and Gynecology, Emory University, Atlanta, GA, USA.
Lesley ConradDepartment of Obstetrics and Gynecology, Emory University, Atlanta, GA, USA.
Isabelle ScottGrady Memorial Hospital, Atlanta, GA, USA.
Tony Y EngRadiation Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Konstantinos T KonstantinidisSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.
Deborah W BrunerNell Hodgson Woodruff School of Nursing, Emory University, Atlanta, GA, USA.
Emory University · USGeorgia Institute of Technology · USGrady Memorial Hospital · US

Funding

Association Tests of Rare Variants Using Sequence Reads without Calling GenotypesR01GM116065 · NIGMS · EMORY UNIVERSITY · PI HU, YIJUAN · 2015 to 2019
$1.5M
Exploring the Microbiome-Gut-Brain Axis in Psychoneurological Symptoms for Children with Solid TumorsK99NR017897 · NINR · EMORY UNIVERSITY · PI BAI, JINBING · 2018 to 2019
$181k
NIGMS NIH HHS R01 GM116065NINR NIH HHS K99 NR017897
6 · The paper itself

Abstract

backgroundWhile the importance of commensal microbes in vaginal health is well appreciated, little is known about the effects of gynecological cancer (GynCa) and radiation therapy (RT) on the vaginal microbiome (VM) of postmenopausal women.

methodsWe studied women with GynCa, pre- (N = 65) and post-RT (N = 25) and a group of healthy controls (N = 67) by sequencing the V4 region of the 16S rRNA gene from vaginal swabs and compared the diversity and composition of VMs between the three groups accounting for potential confounding factors in multivariate analysis of variance.

resultsComparisons of cancer vs healthy groups revealed that Lactobacillus and Bifidobacterium have significantly higher relative abundance in the healthy group, while the cancer group was enriched in 16 phylogroups associated with bacterial vaginosis (BV) and inflammation, including Sneathia, Prevotella, Peptoniphilus, Fusobacterium, Anaerococcus, Dialister, Moryella, and Peptostreptococcus. In our sample, RT affected the α-diversity and correlated with higher abundance of typically rare VM species, including several members of the Lacnospiraceae family, a taxon previously linked to vaginal dysbiosis. In addition to cancer and treatment modalities, age and vaginal pH were identified as significant parameters that structure the VM.

conclusionsThis is among the first reports identifying VM changes among postmenopausal women with cancer. RT alone seems to affect several phylogroups (12 bacterial genera), while gynecological cancer and its treatment modalities are associated with even greater significant shifts in the vaginal microbiota including the enrichment of opportunistic bacterial pathogens, which warrants further attention.

Indexed as

BacteriaCase-Control StudiesFemaleFollow-Up StudiesGenital Neoplasms, FemaleHumansMiddle AgedPrognosisRadiotherapyRNA, Ribosomal, 16SVaginaRNA, Ribosomal, 16S16S rRNA genegynecologic cancerpostmenopausal womenradiation therapyvaginal microbiota

Identifiers

PMID32237205
PMCPMC7286461
OpenAlexW3015115969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.